NCT03273192
- Conditions
- Bioequivalence, Phase 1
- Locations
-
- Orchidpharmed PK/PD site Tehran, Iran
Clinical trial condition
Bioequivalence
Explore clinical trials studying Bioequivalence. Study availability and eligibility vary by location and protocol.
143 public trials
2 recruiting studies
Bioequivalence trial results
NCT03273088
- Conditions
- Bioequivalence, Phase 1
- Locations
-
- Orchidpharmed PK/PD site Tehrān, Tehran Province, Iran
NCT03573050
- Conditions
- Bioequivalence
- Locations
-
- SocraTec R&D GmbH, Clinical Pharmacology Unit Erfurt, Thuringia, Germany
NCT03213353
- Conditions
- Bioequivalence, Healthy Volunteers
- Locations
-
- Scientific Research center Eco-Safety LLC Saint Petersburg, Russia
NCT03452306
- Conditions
- Behavior, Bioequivalence, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- Yarosslavl Clinical Hospital #3 Yaroslavl, Russia
NCT03458208
- Conditions
- Behavior, Bioequivalence, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
- Locations
-
- Yarosslavl Clinical Hospital #3 Yaroslavl, Russia
NCT03557580
- Conditions
- Bioequivalence
- Locations
-
- Qingyuan People's Hospital Qingyuan, China
NCT02637037
- Conditions
- Bioequivalence, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Research Site Baltimore, Maryland, United States
NCT03424928
- Conditions
- Bioequivalence, Blood Protein Disorders, Cardiovascular Diseases, +13 more
- Locations
-
- The second hospital of shanxi medical university Taiyuan, Shanxi, China
Completed
Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta
NCT03146988
- Conditions
- Bioequivalence
- Locations
-
- Quotient Clinical Ruddington, Nottingham, United Kingdom